Nathan Connell: $50 Million Gift to Advance Cell and Gene Therapy at Mass General Brigham
Nathan Connell, Clinical Chief of Hematology at Brigham and Women’s Faulkner Hospital, shared a post on LinkedIn:
“Transformational philanthropy is essential to advancing the next era of cellular and gene therapy.
The recently announced $50 million anonymous gift to support cancer research and cell and gene therapy across Mass General Brigham will help strengthen the infrastructure and translational science required to bring these therapies from discovery to patients.
In hematology, we are already beginning to see this shift in real time.
At Brigham and Women’s Hospital, our hemophilia program treated the first patient in New England with gene therapy for hemophilia B last year—a one-time infusion designed to enable the liver to produce factor IX, potentially replacing lifelong prophylactic factor therapy.
For patients who have spent decades managing a chronic bleeding disorder, the possibility that a single treatment could durably restore hemostasis represents a fundamental change in how we think about treatment.
Continued investment in academic gene therapy programs will be critical to expanding access, refining these approaches, and bringing the next generation of therapies to patients.
I am grateful to the visionary donors who are helping to accelerate our work.”
Stay updated with Hemostasis Today.
-
Sep 25, 2026, 10:49Shefina S: From Presenting to Hosting at TRANSCON 2026
-
Sep 25, 2026, 10:37Michelle Leona Cecil: Hemophilia Advocacy and the Power of Community
-
Sep 25, 2026, 10:13Michael Baria: Platelet Concentration and PRP Outcomes in Partial Rotator Cuff Tears
-
Sep 25, 2026, 09:49Haley Coleman: Volunteering to Support Hemophilia Awareness
-
Sep 25, 2026, 08:55Hitarth Mehta: BHMS Students Gain Practical Exposure to Haemophilia Diagnosis
-
Sep 25, 2026, 07:25Varun Capoor: How Therapeutic Apheresis and Transfusion Medicine Can Complement Clinical Management in SCD
-
Sep 25, 2026, 07:14Manshi Kesharwani: SAK-GQDs Modulate Thrombus Burden and Endothelial Function in Deep Vein Thrombosis
-
Sep 25, 2026, 06:20Farjah Hassan Algahtani: How Can We Better Identify Patients at Risk of Blood Clots after Metabolic and Bariatric Surgery?
-
Sep 25, 2026, 05:59Carla Lewis: Kids Conquering Sickle Disease Joins Nemours Children’s Hospital for 2nd Annual Awareness Event